Medicamen Organics Limited — Board Meeting, 14-11-2024: Outcome of Board Meeting

The Board of Directors of Medicamen Organics Limited has convened and approved the un-audited financial results for the half-year ended September 30, 2024. The reported total revenue for this period stands at ₹16.86 crore, with a profit before tax of ₹2.19 crore. Additionally, the board reviewed the Statement of Deviation in the utilization of funds raised through the company's IPO, confirming there has been no deviation in fund usage. The company also holds a positive stance on its recent IPO, having raised ₹105.4 crore, with substantial funds already allocated towards planned activities.